Nasdaq-listed Enlivex Therapeutics is raising $212 million to allocate entirely to the RAIN token for its corporate treasury, marking the first institutional focus on a prediction-market altcoin over Bitcoin or Ethereum. This move highlights growing interest in specialized blockchain sectors like on-chain forecasting. Enlivex Therapeutics, a Nasdaq-listed biotech firm, plans to use 100% of $212 […] Source: https://en.coinotag.com/nasdaq-firm-eyes-rain-token-for-potential-212m-treasury-shift-beyond-bitcoin-ethereum